Search results for "Stroke"
Potential problematic prescribing in older women
Prescription of systemic estrogen therapy after menopause could be a red flag for use of other medications linked to dementia.
https://immattersacp.org/archives/2024/04/potential-problematic-prescribing-in-older-women.htm
1 Apr 2024
Likelihood of smoking cessation after cardiovascular event varies by event type
Patients who had had a myocardial infarction, coronary artery bypass grafting, stroke, or transient ischemic attack were more likely to quit smoking than those who underwent elective percutaneous coronary intervention or had a new diagnosis of peripheral artery disease.
https://immattersacp.org/weekly/archives/2024/02/13/4.htm
13 Feb 2024
Combating the crisis of loneliness
While the COVID-19 pandemic put a spotlight on loneliness, social engagement with friends and family has been falling for the past two decades as feelings of social isolation have increased.
https://immattersacp.org/archives/2023/10/combating-the-crisis-of-loneliness.htm
1 Oct 2023
Risk of ischemic stroke may be higher in afib patients on newer anticoagulants vs. on warfarin
The increase in stroke risk was particularly high among patients taking apixaban and dabigatran, whereas the results for rivaroxaban and edoxaban were more ambiguous.
https://immattersacp.org/weekly/archives/2018/10/23/4.htm
23 Oct 2018
Welcome to I.M. Matters from ACP
This issue announces our new name and includes lead stories on vertigo and grateful patient fundraising.
https://immattersacp.org/archives/2024/01/welcome-to-im-matters-from-acp.htm
1 Jan 2024
Patch monitor screening for atrial fibrillation may be cost-effective in high-risk patients
Wearing patch monitors for two weeks of atrial fibrillation screening provided economic value in gained quality-adjusted life-years for high-risk older patients, according to a new analysis of a randomized trial.
https://immattersacp.org/weekly/archives/2023/11/07/4.htm
7 Nov 2023
Home-based INR monitoring associated with fewer adverse events
An industry-funded, claims-based analysis found that patients on warfarin who tested their international normalized ratio (INR) at home had lower rates of stroke, thromboembolism, and major bleeding than patients whose INRs were measured at physicians' offices or in laboratories.
https://immattersacp.org/weekly/archives/2024/01/02/4.htm
2 Jan 2024
First medication for severe frostbite approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/04/first-medication-for-severe-frostbite-approved.htm
1 Apr 2024
Rosuvastatin, atorvastatin compared on effectiveness, safety in industry-funded trial
Analysis of a randomized trial in South Korea found that patients randomized to rosuvastatin developed type 2 diabetes requiring medication at a rate of 7.2%, compared to 5.3% among those given atorvastatin.
https://immattersacp.org/weekly/archives/2023/10/24/4.htm
24 Oct 2023
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, I.M. Matters Weekly from ACP.
https://immattersacp.org/archives/2024/03/latest-updates-on-acps-priorities-initiatives.htm
1 Mar 2024